Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
December 15, 2017 – Aclaris Therapeutics announced the FDA approval of Eskata (hydrogen peroxide) for the treatment of seborrheic keratoses (SK) that are raised.
